In a groundbreaking clinical trial, the drug lenacapavir achieved a 100% success rate in preventing HIV infections among women and girls. This trial marks the most effective HIV prevention method ever recorded. Lenacapavir, already approved for treating HIV, requires only two injections per year for full protection. Recently, a phase I trial for once-yearly injections of lenacapavir was presented at a conference in San Francisco. These early trials focused on safety in healthy volunteers and showed promising results. The potential of lenacapavir to be administered annually could significantly enhance HIV prevention strategies worldwide.
Source: www.technologyreview.com

Related Links
Related Videos
Related X Posts
Stats Bag
@StatsBag
·
11h
100% Success Rate: The Annual Shot That Could Revolutionize HIV Prevention#HIV #HIVprevention #Lenacapavir #clinicaltrials #StatsBagMore health news & stats: https://statsbag.com/category/news/health/…
Jesse Morse, M.D.
@DrJesseMorse
·
Feb 28
Health insurance companies are VERY good at predicting decline and death.Even though most Americans still continue to not believe, COVID and the COVID vaccine have changed our world indefinitely.The sooner that you come to grips with this, the easier it will be to protect
Dr. Mike
@mybarra
·
Mar 12
A once-yearly injection of an antiviral could be a total game changer in HIV prevention. It’s a step towards more accessible, long-term protection. This could further transform how we approach #HIVPrevention.
Julia Kwasniewska
@J_Kwasniewska
·
Mar 12
Promising news! New annual injection designed to prevent #HIV has completed an early safety trial. Long-acting ARVs would play a key role in the global HIV response —but only if they become available to everyone who needs them, regardless of ability to pay
Prof Peter Hotez MD PhD
@PeterHotez
·
Feb 6
Thanks for the question, and the ANS = $0 from both big pharma & cable news channels. The opposite: I develop low cost, often patent-free vaccines that actually bypass big pharma, 100 million doses administered at $2-4 per dose, showing there’s another path
Biotech2k
@Biotech2k1
·
Mar 11
I see 1 billion doses at 1 perday is 2.739 million patients a year. Even at $2,500 per year per patient, that is about $6.8 billion sales.



![[Multi SUB] (全集)美女總裁沒想到那個幫她公司上市的隱藏頂級大佬竟然就是被她拋棄的廢物老公? !#都市 #逆袭 #最火短剧推荐 #MiniDrama #精彩大陆短剧](https://i.ytimg.com/vi/fsRdOSJ8sUw/mqdefault.jpg)










